EC Makes Supply Agreement with GSK and Vir Biotechnology for mAb COVID-19 Treatment

The European Commission has entered into a supply agreement with GlaxoSmithKline and Vir Biotechnology for up to 220,000 doses of sotrovimab, an investigational mAb for treating COVID-19.